Over the past 12 months, 4 insiders at AMICUS THERAPEUTICS, INC. filed 13 open-market SEC Form 4 transactions on FOLD: 0 purchases worth $0 and 13 sales worth $5.4M. Insiders have been net sellers over this period. The most recent filing was on Mar 2, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 26 | Bradley L CampbellPresident and CEO | SELL | 22.5K | $14.35 | $323K |
| Jan 20, 26 | Bradley L CampbellPresident and CEO | SELL | 75.0K | $14.31 | $1.1M |
| Dec 19, 25 | David Michael ClarkChief People Officer | SELL | 25.6K | $14.17 | $363K |
| Dec 15, 25 | Bradley L CampbellPresident and CEO | SELL | 77.9K | $10.86 | $846K |
| Dec 15, 25 | David Michael ClarkChief People Officer | SELL | 25.6K | $11.00 | $282K |
| Dec 1, 25 | Bradley L CampbellPresident and CEO | SELL | 14.6K | $10.01 | $146K |
| Nov 26, 25 | Ellen RosenbergChief Legal Officer | SELL | 23.6K | $10.00 | $236K |
| Nov 25, 25 | Ellen RosenbergChief Legal Officer | SELL | 36.0K | $10.00 | $360K |
| Nov 24, 25 | Bradley L CampbellPresident and CEO | SELL | 14.6K | $10.04 | $146K |
| Nov 24, 25 | Jeff CastelliChief Development Officer | SELL | 76.2K | $10.16 | $774K |
| Nov 24, 25 | David Michael ClarkChief People Officer | SELL | 25.6K | $10.10 | $259K |
| Nov 24, 25 | Ellen RosenbergChief Legal Officer | SELL | 36.0K | $10.06 | $362K |
| Nov 4, 25 | David Michael ClarkChief People Officer | SELL | 25.6K | $9.51 | $244K |
| Feb 19, 25 | Bradley L CampbellPresident and CEO | SELL | 400 | $10.00 | $4K |
| Dec 2, 24 | Bradley L CampbellPresident and CEO | SELL | 7.5K | $10.02 | $75K |
| Nov 6, 24 | Bradley L CampbellPresident and CEO | SELL | 7.9K | $12.50 | $99K |
| Nov 1, 24 | Bradley L CampbellPresident and CEO | SELL | 7.5K | $11.46 | $86K |
| Oct 1, 24 | Bradley L CampbellPresident and CEO | SELL | 7.5K | $10.60 | $80K |
| Sep 3, 24 | Bradley L CampbellPresident and CEO | SELL | 7.5K | $11.71 | $88K |
| Aug 1, 24 | Bradley L CampbellPresident and CEO | SELL | 7.5K | $10.34 | $78K |
| Jul 5, 24 | Bradley L CampbellPresident and CEO | SELL | 6.1K | $10.00 | $61K |
| Jul 1, 24 | Bradley L CampbellPresident and CEO | SELL | 1.4K | $10.00 | $14K |
| Jun 3, 24 | Bradley L CampbellPresident and CEO | SELL | 7.5K | $10.00 | $75K |
| May 1, 24 | Bradley L CampbellPresident and CEO | SELL | 7.5K | $10.07 | $76K |
| Apr 1, 24 | Bradley L CampbellPresident and CEO | SELL | 7.5K | $11.67 | $88K |
| Mar 5, 24 | Margaret G McGlynnDirector | SELL | 7.5K | $13.40 | $101K |
| Mar 4, 24 | Margaret G McGlynnDirector | SELL | 7.5K | $13.29 | $100K |
| Mar 1, 24 | Bradley L CampbellPresident and CEO | SELL | 15.8K | $13.14 | $208K |
| Mar 1, 24 | John F CrowleyExecutive Chairman | SELL | 29.2K | $13.35 | $390K |
| Feb 15, 24 | Bradley L CampbellPresident and CEO | SELL | 4.2K | $14.00 | $58K |
| Feb 15, 24 | David Michael ClarkChief People Officer | SELL | 4.4K | $14.00 | $62K |
| Feb 15, 24 | John F CrowleyExecutive Chairman | SELL | 31.6K | $13.81 | $437K |
| Feb 7, 24 | Ellen RosenbergChief Legal Officer | SELL | 29.6K | $13.00 | $385K |
| Feb 6, 24 | Ellen RosenbergChief Legal Officer | SELL | 400 | $13.00 | $5K |
| Feb 1, 24 | Bradley L CampbellPresident and CEO | SELL | 15.8K | $12.56 | $199K |
| Feb 1, 24 | John F CrowleyExecutive Chairman | SELL | 31.6K | $12.62 | $399K |
| Jan 22, 24 | John F CrowleyExecutive Chairman | SELL | 55.3K | $12.36 | $684K |
| Jan 16, 24 | John F CrowleyExecutive Chairman | SELL | 31.6K | $12.78 | $404K |
| Jan 10, 24 | John F CrowleyExecutive Chairman | SELL | 31.6K | $13.65 | $432K |
| Jan 9, 24 | David Michael ClarkChief People Officer | SELL | 1.4K | $14.00 | $19K |
| Jan 9, 24 | Samantha ProutChief Accounting Officer | SELL | 1.3K | $14.00 | $19K |
| Jan 8, 24 | David Michael ClarkChief People Officer | SELL | 8.7K | $14.00 | $122K |
| Jan 8, 24 | Samantha ProutChief Accounting Officer | SELL | 30.8K | $14.00 | $431K |
| Jan 2, 24 | Bradley L CampbellPresident and CEO | SELL | 8.3K | $14.24 | $119K |
| Jan 2, 24 | Ellen RosenbergChief Legal Officer | SELL | 30.0K | $14.21 | $426K |
| Dec 28, 23 | Jeff CastelliChief Development Officer | SELL | 17.4K | $14.52 | $253K |
| Dec 27, 23 | Ellen RosenbergChief Legal Officer | SELL | 5.0K | $14.07 | $70K |
| Dec 26, 23 | Samantha ProutChief Accounting Officer | SELL | 7.7K | $14.00 | $107K |
| Dec 26, 23 | Ellen RosenbergChief Legal Officer | SELL | 30.0K | $14.00 | $420K |
| Dec 20, 23 | Jeff CastelliChief Development Officer | SELL | 1.7K | $13.10 | $22K |
Over the past 12 months, insiders at AMICUS THERAPEUTICS, INC. filed 0 open-market purchases worth $0 and 13 sales worth $5.4M on FOLD, which makes them net sellers over the period. The most recent Form 4 was filed on Mar 2, 26.
4 different insiders at AMICUS THERAPEUTICS, INC. filed open-market SEC Form 4 transactions on FOLD over the last 12 months.
InsiderTape plots every FOLD insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every AMICUS THERAPEUTICS, INC. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →